Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system
Section snippets
Western blotting
The brain from a single 150-g Sprague–Dawley rat was rapidly dissected isolating the cortex, cerebellum, striatum, and hippocampus. Brain regions were disrupted using a glass-teflon homogenizer in five-fold (volume/weight) excess buffer A [25 mM HEPES, 1 mM EDTA, 6 mM MgCl2, 100 μM phenylmethylsulfonyl fluoride (PMSF), 100 μg/ml soybean trypsin inhibitor, and 10 μM/ml leupeptin, pH 7.4 with NaOH]. Homogenates were spun for 5 min at 1000 g, the supernatants were saved, and the pellets were
CB1 receptor distribution by western blotting
Antibodies to the amino terminus (residues 1–77) of the CB1 receptor recognized a major band of ∼63,000 mol. wt in cortex, hippocampus, striatum, and cerebellum (Fig. 1A). A minor band of ∼180,000 mol. wt was also seen. No immunoreactivity was detected in any of these regions when the primary antiserum was preincubated with the immunizing protein (Fig. 1B). The ∼63,000 mol. wt band of the major immunoreactive protein agrees well with the expected molecular weight of the CB1 receptor,[38]as it is
Discussion
The antibodies used in this study were raised against the first 77 residues of the rat CB1 receptor fused to glutathione S-transferase. Tissue sections, cultured neurons, and transfected cell lines[62]were stained with the antibodies, and the staining was blocked when the antibodies were preincubated with the immunizing protein. In the western blots of brain regions, the immunoreactive bands were also abolished by similar preincubation. Further support for the specificity of the antibodies may
Conclusions
In summary, we have used an antibody to the CB1 receptor to determine its distribution in rat CNS. The CB1 receptor is widely distributed in the forebrain and has a more restricted distribution in the midbrain, hindbrain and spinal cord. It appears to be expressed on cell bodies, dendrites, and axons. Many neurons that are identifiable as GABAergic express CB1 receptors suggesting that cannabinoids have an important role in regulating GABAergic neurotransmission. Co-localization studies of CB1
Acknowledgements
The authors express their gratitude to Saundra L. Patrick for technical assistance, Dr Alfred Mansour for sharing his immunohistochemical protocol, Dr Rebecca Burwell for loaning microscope equipment, Dr Charles Ouimet, Dr Ruth Westenbroek, Dr Michael S. Beattie, and Dr Jacqueline Bresnahan for critical reading of the manuscript. We are grateful for the financial support provided by the NIH(NS33247, DA10536 to J.M.W. and K.T., DA10043, MH01083 to J.M.W.; NS01588, NS08174, DA00286, DA08934 to
References (63)
- et al.
Cannabinoid precipitated withdrawal by the selective cannabinoid antagonist, SR 141716A
Eur. J. Pharmac.
(1995) - et al.
Effects of morphine and midazolam on reactivity to peripheral noxious and central aversive stimuli
Neurosci. Biobehav. Rev.
(1990) - et al.
Marijuana's interaction with brain reward systems: update 1991
Pharmac. Biochem. Behav.
(1991) - et al.
Neuronal localization of cannabinoid receptors and second messengers in mutant mouse cerebellum
Brain Res.
(1991) - et al.
Neuronal localization of cannabinoid receptors in the basal ganglia of the rat
Brain Res.
(1991) Inhibition of neuroblastoma adenylyl cyclase by cannabinoid and nantradol compounds
Life Sci.
(1984)- et al.
The cannabinoid receptor: biochemical, anatomical, and behavioral characterization
Trends Neurosci.
(1990) - et al.
Localization of a G protein-coupled inwardly rectifying K+ channel, CIR, in the rat brain
Neuroscience
(1997) - et al.
Effect of superior colliculus lesions on sensory unit responses in the intralaminar thalamus of the rat
Brain Res.
(1992) - et al.
Distribution of neuronal cannabinoid receptor in the adult rat brain: a comparative receptor binding radioautography and in situ hybridization histochemistry
Neuroscience
(1992)
Immunohistochemical localization of the cloned k1 receptor in the rat CNS and pituitary
Neuroscience
Effects of a cannabinoid on spontaneous and evoked neuronal activity in substantia nigra pars reticulata
Eur. J. Pharmac.
Electrophysiological effects of a cannabinoid on neural activity in the globus pallidus
Eur. J. Pharmac.
Enhancement by chlordiazepoxide of catalepsy induced in rats by intravenous or intrapallidal injections of enantiomeric cannabinoids
Neuropharmacology
The dimethylheptyl derivative of (-)-Δ9-tetrahydrocannabinol reduces the turnover of gamma-aminobutyric acid in the septum and nucleus accumbens
Life Sci.
Effects of intranigral cannabinoids on rotational behavior in rats: interactions with the dopaminergic system
Neurosci. Lett.
Rat brain cannabinoid receptors are N-linked glycosylated proteins
Life Sci.
Immunocytochemical localization of opiomelanocortin-derived peptides in the adult rat spinal cord
Brain Res.
Physical withdrawal in rats tolerant to Δ9-tetrahydrocannabinol precipitated by a cannabinoid receptor antagonist
Eur. J. Pharmac.
Suppression of noxious stimulus-evoked expression of fos-like immunoreactivity in rat spinal cord by a selective cannabinoid agonist
Neuroscience
Cannabinoid receptor binding and messenger RNA expression in human brain: an in vitro receptor autoradiography and in situ hybridization histochemistry study of normal aged and Alzheimer's brains
Neuroscience
Δ9-THC differentially affects sensory-evoked potentials in the rat dentate gyrus
J. Pharmac. exp. Ther.
Prevention by cannabinoid antagonist, SR 141716A, of cannabinoid-mediated blockade of long-term potentiation in the rat hippocampal slice
Br. J. Pharmac.
Cannabinoids modulate voltage-sensitive potassium A current in hippocampal neurons via a cAMP-dependent process
J. Pharmac. exp. Ther.
The effects of delta-9-THC on mechanisms of learning and memory
NIDA Res. Monogr.
Isolation and structure of a brain constituent that binds to the cannabinoid receptor
Science
Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal
Science
Electrically evoked acetylcholine release from hippocampal slices is inhibited by the cannabinoid receptor agonist, WIN 55212-2, and is potentiated by the cannabinoid antagonist SR 141716A
J. Pharmac. exp. Ther.
Cited by (1399)
Anti-allodynic and medullary modulatory effects of a single dose of delta-9-tetrahydrocannabinol (THC) in neuropathic rats tolerant to morphine
2023, Progress in Neuro-Psychopharmacology and Biological PsychiatryFatty acid-binding protein 5 differentially impacts dopamine signaling independent of sex and environment
2023, Addiction NeuroscienceMechanisms of cannabinoid tolerance
2023, Biochemical PharmacologyWomen are taking the hit: Examining the unique consequences of cannabis use across the female lifespan
2023, Frontiers in Neuroendocrinology